PT1805192E - Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumorais - Google Patents
Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumoraisInfo
- Publication number
- PT1805192E PT1805192E PT58211251T PT05821125T PT1805192E PT 1805192 E PT1805192 E PT 1805192E PT 58211251 T PT58211251 T PT 58211251T PT 05821125 T PT05821125 T PT 05821125T PT 1805192 E PT1805192 E PT 1805192E
- Authority
- PT
- Portugal
- Prior art keywords
- analogs
- salts
- tumor agents
- isophosphoramide mustard
- isophosphoramide
- Prior art date
Links
- BKCJZNIZRWYHBN-UHFFFAOYSA-N Isophosphamide mustard Chemical class ClCCNP(=O)(O)NCCCl BKCJZNIZRWYHBN-UHFFFAOYSA-N 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/222—Amides of phosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62208704P | 2004-10-25 | 2004-10-25 | |
| US67270705P | 2005-04-18 | 2005-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1805192E true PT1805192E (pt) | 2013-01-23 |
Family
ID=35788704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT58211251T PT1805192E (pt) | 2004-10-25 | 2005-10-25 | Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumorais |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US8232262B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP1805192B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5336082B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20130041384A (cg-RX-API-DMAC7.html) |
| CN (3) | CN101087800B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005299385B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2585125C (cg-RX-API-DMAC7.html) |
| DK (2) | DK2336140T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2565929T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1209752A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL182752A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20072478L (cg-RX-API-DMAC7.html) |
| NZ (2) | NZ589418A (cg-RX-API-DMAC7.html) |
| PL (1) | PL1805192T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1805192E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1805192T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006047575A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2585125C (en) | 2004-10-25 | 2014-04-22 | Lee Morgan | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| US7964583B2 (en) | 2006-02-17 | 2011-06-21 | Ziopharm Oncology, Inc. | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| KR20150139620A (ko) * | 2007-04-06 | 2015-12-11 | 지오팜 온콜로지 인코포레이티드 | 이소포스포르아미드 머스타드의 염 및 이의 동족체 |
| SG183657A1 (en) * | 2008-07-31 | 2012-09-27 | Ziopharm Oncology Inc | Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| WO2010099213A1 (en) | 2009-02-24 | 2010-09-02 | Dekk-Tec, Inc. | Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents |
| CN102659841B (zh) * | 2012-04-24 | 2015-03-25 | 石家庄学院 | 多元酚磷酰胺衍生物及其制备方法与应用 |
| US10172789B2 (en) | 2013-01-24 | 2019-01-08 | Palvella Therapeutics Llc | Compositions for transdermal delivery of mTOR inhibitors |
| CN108348780A (zh) * | 2015-09-10 | 2018-07-31 | 贝克顿·迪金森公司 | 用作用于环磷酰胺和异环磷酰胺的免疫分析的免疫原和分析缀合物的环磷酰胺类似物 |
| WO2018129364A1 (en) | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Anhydrous compositions of mtor inhibitors and methods of use |
| EP3684944B1 (en) | 2017-09-21 | 2025-01-01 | Becton, Dickinson and Company | Hazardous contaminant collection kit and rapid testing |
| CN111107939B (zh) | 2017-09-21 | 2022-04-12 | 贝克顿·迪金森公司 | 引导有害污染物样品的收集的系统和模板及使用其的方法 |
| USD859683S1 (en) | 2017-09-21 | 2019-09-10 | Becton, Dickinson And Company | Collection device |
| JP7223749B2 (ja) | 2017-09-21 | 2023-02-16 | ベクトン・ディキンソン・アンド・カンパニー | 危険汚染物質の試験における高ダイナミックレンジの分析器 |
| EP3817743A4 (en) | 2018-07-02 | 2022-07-06 | Palvella Therapeutics, Inc. | ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE |
| WO2020068657A1 (en) * | 2018-09-25 | 2020-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof |
| CN113383222A (zh) | 2019-01-28 | 2021-09-10 | 贝克顿·迪金森公司 | 具有集成的拭子和测试装置的有害污染物收集装置 |
| CN111973583A (zh) * | 2020-07-29 | 2020-11-24 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用 |
| CN111943979B (zh) | 2020-10-19 | 2020-12-22 | 南京卓康医药科技有限公司 | 一种异环磷酰胺中间体及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU427945A1 (ru) | 1972-07-24 | 1974-05-15 | Институт элементоорганических соединений | СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ |
| JPS5159886A (cg-RX-API-DMAC7.html) | 1974-11-20 | 1976-05-25 | Shionogi Seiyaku Kk | |
| ZA851062B (en) * | 1984-03-01 | 1985-11-27 | Asta Werke Ag Chem Fab | Salts of oxazaphosphorine derivatives and process for their production |
| PL264222A1 (en) * | 1986-02-22 | 1988-04-14 | Method of obtaining novel heterocyclic compounds with 2-(2-/n,n-bis-(2-chloroethyl)-diamido-phosphoryloxy/ethyl)group | |
| US4841085A (en) * | 1986-06-30 | 1989-06-20 | Board Of Regents, University Of Texas System | Aldophosphamides |
| US5055459A (en) * | 1986-06-30 | 1991-10-08 | Board Of Regents, The University Of Texas | Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates |
| WO1993021173A1 (en) | 1992-04-17 | 1993-10-28 | Abbott Laboratories | Taxol derivatives |
| US5468499A (en) * | 1993-11-15 | 1995-11-21 | Ohio State University | Liposomes containing the salt of phosphoramide mustard and related compounds |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| JP4629238B2 (ja) * | 1999-05-24 | 2011-02-09 | サザン・リサーチ・インスティテュート | イソホスホアミドマスタード・アナログ及びその使用 |
| CO5280224A1 (es) | 2000-02-02 | 2003-05-30 | Univ Florida State Res Found | Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen |
| AU2001248201B2 (en) | 2000-04-13 | 2006-12-14 | Hsc Research And Development Limited Partnership | Compounds for modulating cell proliferation |
| DE10064312C2 (de) * | 2000-12-22 | 2003-05-22 | Degussa | Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung |
| ATE350383T1 (de) | 2002-08-23 | 2007-01-15 | Sloan Kettering Inst Cancer | Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen |
| CA2585125C (en) * | 2004-10-25 | 2014-04-22 | Lee Morgan | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| KR20150139620A (ko) | 2007-04-06 | 2015-12-11 | 지오팜 온콜로지 인코포레이티드 | 이소포스포르아미드 머스타드의 염 및 이의 동족체 |
| SG183657A1 (en) * | 2008-07-31 | 2012-09-27 | Ziopharm Oncology Inc | Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
-
2005
- 2005-10-25 CA CA2585125A patent/CA2585125C/en not_active Expired - Fee Related
- 2005-10-25 NZ NZ589418A patent/NZ589418A/en not_active IP Right Cessation
- 2005-10-25 AU AU2005299385A patent/AU2005299385B2/en not_active Ceased
- 2005-10-25 ES ES10178422.1T patent/ES2565929T3/es not_active Expired - Lifetime
- 2005-10-25 ES ES05821125T patent/ES2397165T3/es not_active Expired - Lifetime
- 2005-10-25 KR KR1020137008506A patent/KR20130041384A/ko not_active Withdrawn
- 2005-10-25 CN CN200580044803.6A patent/CN101087800B/zh not_active Expired - Fee Related
- 2005-10-25 WO PCT/US2005/038523 patent/WO2006047575A2/en not_active Ceased
- 2005-10-25 EP EP05821125A patent/EP1805192B1/en not_active Expired - Lifetime
- 2005-10-25 CN CN2013100286502A patent/CN103172662A/zh active Pending
- 2005-10-25 PL PL05821125T patent/PL1805192T3/pl unknown
- 2005-10-25 KR KR1020077011864A patent/KR101292026B1/ko not_active Expired - Fee Related
- 2005-10-25 PT PT58211251T patent/PT1805192E/pt unknown
- 2005-10-25 DK DK10178422.1T patent/DK2336140T3/en active
- 2005-10-25 US US11/666,215 patent/US8232262B2/en not_active Expired - Fee Related
- 2005-10-25 DK DK05821125.1T patent/DK1805192T3/da active
- 2005-10-25 EP EP10178422.1A patent/EP2336140B1/en not_active Expired - Lifetime
- 2005-10-25 SI SI200531655T patent/SI1805192T1/sl unknown
- 2005-10-25 NZ NZ555323A patent/NZ555323A/en not_active IP Right Cessation
- 2005-10-25 JP JP2007538185A patent/JP5336082B2/ja not_active Expired - Fee Related
- 2005-10-25 US US11/257,766 patent/US7678778B2/en not_active Expired - Fee Related
- 2005-10-25 EP EP10178414A patent/EP2336139A3/en not_active Withdrawn
- 2005-10-25 CN CN201410730089.7A patent/CN104558023A/zh active Pending
-
2007
- 2007-04-23 IL IL182752A patent/IL182752A/en not_active IP Right Cessation
- 2007-05-16 NO NO20072478A patent/NO20072478L/no not_active Application Discontinuation
-
2011
- 2011-03-24 IL IL211935A patent/IL211935A0/en unknown
- 2011-03-24 IL IL211936A patent/IL211936A/en not_active IP Right Cessation
-
2012
- 2012-07-03 US US13/541,522 patent/US8795659B2/en not_active Expired - Fee Related
-
2014
- 2014-07-10 US US14/328,125 patent/US9346836B2/en not_active Expired - Fee Related
-
2015
- 2015-10-22 HK HK15110402.4A patent/HK1209752A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL211936A0 (en) | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents | |
| AP2006003768A0 (en) | TetraazabenzoÄeÜazulene derivatives and analogs tehereof | |
| ZA200802501B (en) | Indenoisoquinolinone analogs and methods of use thereof | |
| PL1802579T3 (pl) | Pochodne 3-aryloaminopirydynowe | |
| IL185747A0 (en) | Use of supplemental assignments | |
| EP1778618A4 (en) | SYNTHESIS OF TRIETHYLENETETRAMINES | |
| IL184036A0 (en) | Preparation of rosuvastatin | |
| EP1730148A4 (en) | USE OF AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS | |
| PL2335782T3 (pl) | Zastosowanie kompozycji zawierającej HFCO-1233zd | |
| EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
| IL176932A0 (en) | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof | |
| GB0417401D0 (en) | Stabilised prostaglandin composition | |
| EP1928489A4 (en) | Ghrelin Analogs | |
| IL176922A0 (en) | Compositions and methods of use of a-type procyanidins | |
| EP1796676A4 (en) | TRANSDERMALE ADMINISTRATION OF PHYCOTOXINES | |
| PL1778621T3 (pl) | Wytwarzanie jodiksanolu | |
| EP1945258A4 (en) | FDT RELATED COMPOUNDS AND THEIR ANALOGUES | |
| EP1711484A4 (en) | SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES | |
| PL1740204T3 (pl) | Lecznicze zastosowanie alfa-mannozydazy | |
| GB0412584D0 (en) | Composition of matter | |
| PT1802209E (pt) | Artigo de vestuário | |
| IL187948A0 (en) | Preparation of rosuvastatin | |
| IL179962A0 (en) | Compositions and methods of use of dimer digallates | |
| ZA200706110B (en) | Pharmaceutical formulations of gallium salts | |
| IL178184A0 (en) | Synthesis of pyrrole-2-carbonitriles |